TCPQ_HUMAN - dbPTM
TCPQ_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TCPQ_HUMAN
UniProt AC P50990
Protein Name T-complex protein 1 subunit theta
Gene Name CCT8
Organism Homo sapiens (Human).
Sequence Length 548
Subcellular Localization Cytoplasm . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Cytoplasm, cytoskeleton, cilium basal body .
Protein Description Molecular chaperone; assists the folding of proteins upon ATP hydrolysis. As part of the BBS/CCT complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. Known to play a role, in vitro, in the folding of actin and tubulin..
Protein Sequence MALHVPKAPGFAQMLKEGAKHFSGLEEAVYRNIQACKELAQTTRTAYGPNGMNKMVINHLEKLFVTNDAATILRELEVQHPAAKMIVMASHMQEQEVGDGTNFVLVFAGALLELAEELLRIGLSVSEVIEGYEIACRKAHEILPNLVCCSAKNLRDIDEVSSLLRTSIMSKQYGNEVFLAKLIAQACVSIFPDSGHFNVDNIRVCKILGSGISSSSVLHGMVFKKETEGDVTSVKDAKIAVYSCPFDGMITETKGTVLIKTAEELMNFSKGEENLMDAQVKAIADTGANVVVTGGKVADMALHYANKYNIMLVRLNSKWDLRRLCKTVGATALPRLTPPVLEEMGHCDSVYLSEVGDTQVVVFKHEKEDGAISTIVLRGSTDNLMDDIERAVDDGVNTFKVLTRDKRLVPGGGATEIELAKQITSYGETCPGLEQYAIKKFAEAFEAIPRALAENSGVKANEVISKLYAVHQEGNKNVGLDIEAEVPAVKDMLEAGILDTYLGKYWAIKLATNAAVTVLRVDQIIMAKPAGGPKPPSGKKDWDDDQND
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MALHVPKAP
------CCCCCCCCC
13.33-
7Ubiquitination-MALHVPKAPGFAQM
-CCCCCCCCCCHHHH
67.1521890473
7Acetylation-MALHVPKAPGFAQM
-CCCCCCCCCCHHHH
67.1519608861
7Malonylation-MALHVPKAPGFAQM
-CCCCCCCCCCHHHH
67.1526320211
7Ubiquitination-MALHVPKAPGFAQM
-CCCCCCCCCCHHHH
67.1521890473
14SulfoxidationKAPGFAQMLKEGAKH
CCCCHHHHHHHHHHH
5.3228465586
16UbiquitinationPGFAQMLKEGAKHFS
CCHHHHHHHHHHHCC
49.0821890473
16AcetylationPGFAQMLKEGAKHFS
CCHHHHHHHHHHHCC
49.0825953088
16MalonylationPGFAQMLKEGAKHFS
CCHHHHHHHHHHHCC
49.0826320211
16UbiquitinationPGFAQMLKEGAKHFS
CCHHHHHHHHHHHCC
49.0821890473
18UbiquitinationFAQMLKEGAKHFSGL
HHHHHHHHHHHCCCH
38.03-
20UbiquitinationQMLKEGAKHFSGLEE
HHHHHHHHHCCCHHH
56.9121890473
20AcetylationQMLKEGAKHFSGLEE
HHHHHHHHHCCCHHH
56.9116916647
20MalonylationQMLKEGAKHFSGLEE
HHHHHHHHHCCCHHH
56.9126320211
20UbiquitinationQMLKEGAKHFSGLEE
HHHHHHHHHCCCHHH
56.9121890473
23PhosphorylationKEGAKHFSGLEEAVY
HHHHHHCCCHHHHHH
42.0330266825
30PhosphorylationSGLEEAVYRNIQACK
CCHHHHHHHHHHHHH
12.6525159151
35UbiquitinationAVYRNIQACKELAQT
HHHHHHHHHHHHHHH
11.53-
36GlutathionylationVYRNIQACKELAQTT
HHHHHHHHHHHHHHH
1.7022555962
36S-palmitoylationVYRNIQACKELAQTT
HHHHHHHHHHHHHHH
1.7026865113
372-HydroxyisobutyrylationYRNIQACKELAQTTR
HHHHHHHHHHHHHHC
59.80-
37AcetylationYRNIQACKELAQTTR
HHHHHHHHHHHHHHC
59.8026051181
37UbiquitinationYRNIQACKELAQTTR
HHHHHHHHHHHHHHC
59.8021906983
43UbiquitinationCKELAQTTRTAYGPN
HHHHHHHHCCCCCCC
17.59-
54UbiquitinationYGPNGMNKMVINHLE
CCCCHHHHHHHHHHH
26.1721890473
54UbiquitinationYGPNGMNKMVINHLE
CCCCHHHHHHHHHHH
26.1721890473
55SulfoxidationGPNGMNKMVINHLEK
CCCHHHHHHHHHHHH
2.8830846556
62UbiquitinationMVINHLEKLFVTNDA
HHHHHHHHHHCCCCH
54.2921890473
622-HydroxyisobutyrylationMVINHLEKLFVTNDA
HHHHHHHHHHCCCCH
54.29-
62AcetylationMVINHLEKLFVTNDA
HHHHHHHHHHCCCCH
54.2925953088
62UbiquitinationMVINHLEKLFVTNDA
HHHHHHHHHHCCCCH
54.2921890473
66PhosphorylationHLEKLFVTNDAATIL
HHHHHHCCCCHHHHH
21.7522210691
71PhosphorylationFVTNDAATILRELEV
HCCCCHHHHHHHHHC
23.4327050516
119UbiquitinationLELAEELLRIGLSVS
HHHHHHHHHHCCCHH
4.19-
133UbiquitinationSEVIEGYEIACRKAH
HHHHCCHHHHCHHHH
34.66-
138AcetylationGYEIACRKAHEILPN
CHHHHCHHHHHHHCC
54.7126051181
138UbiquitinationGYEIACRKAHEILPN
CHHHHCHHHHHHHCC
54.71-
148S-nitrosocysteineEILPNLVCCSAKNLR
HHHCCCEEEECCCCC
1.38-
148S-nitrosylationEILPNLVCCSAKNLR
HHHCCCEEEECCCCC
1.3822178444
149S-nitrosocysteineILPNLVCCSAKNLRD
HHCCCEEEECCCCCC
3.27-
149GlutathionylationILPNLVCCSAKNLRD
HHCCCEEEECCCCCC
3.2722555962
149S-nitrosylationILPNLVCCSAKNLRD
HHCCCEEEECCCCCC
3.2722178444
150PhosphorylationLPNLVCCSAKNLRDI
HCCCEEEECCCCCCH
36.8328450419
152UbiquitinationNLVCCSAKNLRDIDE
CCEEEECCCCCCHHH
39.9721890473
152UbiquitinationNLVCCSAKNLRDIDE
CCEEEECCCCCCHHH
39.9721890473
1522-HydroxyisobutyrylationNLVCCSAKNLRDIDE
CCEEEECCCCCCHHH
39.97-
152AcetylationNLVCCSAKNLRDIDE
CCEEEECCCCCCHHH
39.9725953088
152MalonylationNLVCCSAKNLRDIDE
CCEEEECCCCCCHHH
39.9726320211
152UbiquitinationNLVCCSAKNLRDIDE
CCEEEECCCCCCHHH
39.9721890473
161PhosphorylationLRDIDEVSSLLRTSI
CCCHHHHHHHHHHHH
17.1420873877
162PhosphorylationRDIDEVSSLLRTSIM
CCHHHHHHHHHHHHH
36.2825262027
171UbiquitinationLRTSIMSKQYGNEVF
HHHHHHHHHHCCHHH
30.1121890473
1712-HydroxyisobutyrylationLRTSIMSKQYGNEVF
HHHHHHHHHHCCHHH
30.11-
171AcetylationLRTSIMSKQYGNEVF
HHHHHHHHHHCCHHH
30.1127452117
171UbiquitinationLRTSIMSKQYGNEVF
HHHHHHHHHHCCHHH
30.1121906983
173PhosphorylationTSIMSKQYGNEVFLA
HHHHHHHHCCHHHHH
26.1728152594
206AcetylationVDNIRVCKILGSGIS
CCCEEEEEECCCCCC
37.80-
206UbiquitinationVDNIRVCKILGSGIS
CCCEEEEEECCCCCC
37.80-
206AcetylationVDNIRVCKILGSGIS
CCCEEEEEECCCCCC
37.8026051181
210PhosphorylationRVCKILGSGISSSSV
EEEEECCCCCCCHHH
29.5221406692
213PhosphorylationKILGSGISSSSVLHG
EECCCCCCCHHHEEC
27.9121406692
214PhosphorylationILGSGISSSSVLHGM
ECCCCCCCHHHEECE
25.3921406692
215PhosphorylationLGSGISSSSVLHGMV
CCCCCCCHHHEECEE
20.0621406692
216UbiquitinationGSGISSSSVLHGMVF
CCCCCCHHHEECEEE
30.55-
216PhosphorylationGSGISSSSVLHGMVF
CCCCCCHHHEECEEE
30.5521406692
2242-HydroxyisobutyrylationVLHGMVFKKETEGDV
HEECEEEECCCCCCC
37.99-
224AcetylationVLHGMVFKKETEGDV
HEECEEEECCCCCCC
37.9925038526
224SumoylationVLHGMVFKKETEGDV
HEECEEEECCCCCCC
37.9928112733
224UbiquitinationVLHGMVFKKETEGDV
HEECEEEECCCCCCC
37.99-
225AcetylationLHGMVFKKETEGDVT
EECEEEECCCCCCCC
59.4023236377
225UbiquitinationLHGMVFKKETEGDVT
EECEEEECCCCCCCC
59.4017370265
227PhosphorylationGMVFKKETEGDVTSV
CEEEECCCCCCCCCC
54.9020068231
232PhosphorylationKETEGDVTSVKDAKI
CCCCCCCCCCCCCEE
32.3229255136
233PhosphorylationETEGDVTSVKDAKIA
CCCCCCCCCCCCEEE
27.3329255136
235UbiquitinationEGDVTSVKDAKIAVY
CCCCCCCCCCEEEEE
52.30-
235AcetylationEGDVTSVKDAKIAVY
CCCCCCCCCCEEEEE
52.3025953088
235UbiquitinationEGDVTSVKDAKIAVY
CCCCCCCCCCEEEEE
52.3017370265
2382-HydroxyisobutyrylationVTSVKDAKIAVYSCP
CCCCCCCEEEEEECC
41.13-
238AcetylationVTSVKDAKIAVYSCP
CCCCCCCEEEEEECC
41.1325038526
241UbiquitinationVKDAKIAVYSCPFDG
CCCCEEEEEECCCCC
4.04-
242PhosphorylationKDAKIAVYSCPFDGM
CCCEEEEEECCCCCC
8.7828152594
243PhosphorylationDAKIAVYSCPFDGMI
CCEEEEEECCCCCCE
14.5528152594
244GlutathionylationAKIAVYSCPFDGMIT
CEEEEEECCCCCCEE
1.8222555962
245AcetylationKIAVYSCPFDGMITE
EEEEEECCCCCCEEC
25.1519608861
245UbiquitinationKIAVYSCPFDGMITE
EEEEEECCCCCCEEC
25.1519608861
249SulfoxidationYSCPFDGMITETKGT
EECCCCCCEECCCCE
3.5421406390
251AcetylationCPFDGMITETKGTVL
CCCCCCEECCCCEEE
28.80-
251UbiquitinationCPFDGMITETKGTVL
CCCCCCEECCCCEEE
28.80-
251PhosphorylationCPFDGMITETKGTVL
CCCCCCEECCCCEEE
28.8028450419
253PhosphorylationFDGMITETKGTVLIK
CCCCEECCCCEEEEE
26.5628857561
2542-HydroxyisobutyrylationDGMITETKGTVLIKT
CCCEECCCCEEEEEC
46.48-
254SumoylationDGMITETKGTVLIKT
CCCEECCCCEEEEEC
46.4828112733
254UbiquitinationDGMITETKGTVLIKT
CCCEECCCCEEEEEC
46.48-
256PhosphorylationMITETKGTVLIKTAE
CEECCCCEEEEECHH
17.4428857561
260UbiquitinationTKGTVLIKTAEELMN
CCCEEEEECHHHHHC
37.2121890473
260SumoylationTKGTVLIKTAEELMN
CCCEEEEECHHHHHC
37.2128112733
260UbiquitinationTKGTVLIKTAEELMN
CCCEEEEECHHHHHC
37.2121906983
261PhosphorylationKGTVLIKTAEELMNF
CCEEEEECHHHHHCC
32.10-
266SulfoxidationIKTAEELMNFSKGEE
EECHHHHHCCCCCCC
5.5721406390
269PhosphorylationAEELMNFSKGEENLM
HHHHHCCCCCCCCHH
34.4421815630
270AcetylationEELMNFSKGEENLMD
HHHHCCCCCCCCHHH
67.2323236377
270UbiquitinationEELMNFSKGEENLMD
HHHHCCCCCCCCHHH
67.2321906983
276SulfoxidationSKGEENLMDAQVKAI
CCCCCCHHHHHHHHH
6.3921406390
277UbiquitinationKGEENLMDAQVKAIA
CCCCCHHHHHHHHHH
36.69-
2812-HydroxyisobutyrylationNLMDAQVKAIADTGA
CHHHHHHHHHHHCCC
23.22-
286PhosphorylationQVKAIADTGANVVVT
HHHHHHHCCCCEEEE
29.2223911959
288UbiquitinationKAIADTGANVVVTGG
HHHHHCCCCEEEECC
14.03-
293PhosphorylationTGANVVVTGGKVADM
CCCCEEEECCHHHHH
28.7123911959
2962-HydroxyisobutyrylationNVVVTGGKVADMALH
CEEEECCHHHHHHHH
35.28-
296AcetylationNVVVTGGKVADMALH
CEEEECCHHHHHHHH
35.2826051181
296MalonylationNVVVTGGKVADMALH
CEEEECCHHHHHHHH
35.2826320211
296UbiquitinationNVVVTGGKVADMALH
CEEEECCHHHHHHHH
35.28-
299AcetylationVTGGKVADMALHYAN
EECCHHHHHHHHHHH
26.35-
299UbiquitinationVTGGKVADMALHYAN
EECCHHHHHHHHHHH
26.35-
299AcetylationVTGGKVADMALHYAN
EECCHHHHHHHHHHH
26.3519608861
299UbiquitinationVTGGKVADMALHYAN
EECCHHHHHHHHHHH
26.3519608861
300SulfoxidationTGGKVADMALHYANK
ECCHHHHHHHHHHHH
2.8530846556
304NitrationVADMALHYANKYNIM
HHHHHHHHHHHCCEE
16.84-
304PhosphorylationVADMALHYANKYNIM
HHHHHHHHHHHCCEE
16.8428152594
307AcetylationMALHYANKYNIMLVR
HHHHHHHHCCEEEEE
31.35-
307UbiquitinationMALHYANKYNIMLVR
HHHHHHHHCCEEEEE
31.35-
307AcetylationMALHYANKYNIMLVR
HHHHHHHHCCEEEEE
31.3525953088
307UbiquitinationMALHYANKYNIMLVR
HHHHHHHHCCEEEEE
31.35-
308PhosphorylationALHYANKYNIMLVRL
HHHHHHHCCEEEEEC
15.1023882029
317PhosphorylationIMLVRLNSKWDLRRL
EEEEECCCHHHHHHH
39.4529978859
3182-HydroxyisobutyrylationMLVRLNSKWDLRRLC
EEEECCCHHHHHHHH
43.59-
318AcetylationMLVRLNSKWDLRRLC
EEEECCCHHHHHHHH
43.5919608861
318MalonylationMLVRLNSKWDLRRLC
EEEECCCHHHHHHHH
43.5926320211
318UbiquitinationMLVRLNSKWDLRRLC
EEEECCCHHHHHHHH
43.5919608861
326UbiquitinationWDLRRLCKTVGATAL
HHHHHHHHHHCCCCC
51.3321890473
3262-HydroxyisobutyrylationWDLRRLCKTVGATAL
HHHHHHHHHHCCCCC
51.33-
326AcetylationWDLRRLCKTVGATAL
HHHHHHHHHHCCCCC
51.3323749302
326MalonylationWDLRRLCKTVGATAL
HHHHHHHHHHCCCCC
51.3326320211
326UbiquitinationWDLRRLCKTVGATAL
HHHHHHHHHHCCCCC
51.3321890473
327AcetylationDLRRLCKTVGATALP
HHHHHHHHHCCCCCC
24.1519608861
327PhosphorylationDLRRLCKTVGATALP
HHHHHHHHHCCCCCC
24.1520068231
327UbiquitinationDLRRLCKTVGATALP
HHHHHHHHHCCCCCC
24.1519608861
331PhosphorylationLCKTVGATALPRLTP
HHHHHCCCCCCCCCH
23.8520068231
337PhosphorylationATALPRLTPPVLEEM
CCCCCCCCHHHHHHC
27.1626126808
348AcetylationLEEMGHCDSVYLSEV
HHHCCCCCEEEEECC
35.15-
349PhosphorylationEEMGHCDSVYLSEVG
HHCCCCCEEEEECCC
20.3226126808
351PhosphorylationMGHCDSVYLSEVGDT
CCCCCEEEEECCCCE
14.4126126808
353PhosphorylationHCDSVYLSEVGDTQV
CCCEEEEECCCCEEE
16.7326126808
3672-HydroxyisobutyrylationVVVFKHEKEDGAIST
EEEEEEECCCCCEEE
61.91-
367AcetylationVVVFKHEKEDGAIST
EEEEEEECCCCCEEE
61.9123236377
367MalonylationVVVFKHEKEDGAIST
EEEEEEECCCCCEEE
61.9126320211
367UbiquitinationVVVFKHEKEDGAIST
EEEEEEECCCCCEEE
61.91-
373PhosphorylationEKEDGAISTIVLRGS
ECCCCCEEEEEEECC
16.1420860994
378MethylationAISTIVLRGSTDNLM
CEEEEEEECCCCCHH
26.56-
380PhosphorylationSTIVLRGSTDNLMDD
EEEEEECCCCCHHHH
26.5929255136
381AcetylationTIVLRGSTDNLMDDI
EEEEECCCCCHHHHH
31.56-
381UbiquitinationTIVLRGSTDNLMDDI
EEEEECCCCCHHHHH
31.56-
381AcetylationTIVLRGSTDNLMDDI
EEEEECCCCCHHHHH
31.5619608861
381PhosphorylationTIVLRGSTDNLMDDI
EEEEECCCCCHHHHH
31.5629255136
381UbiquitinationTIVLRGSTDNLMDDI
EEEEECCCCCHHHHH
31.5619608861
385SulfoxidationRGSTDNLMDDIERAV
ECCCCCHHHHHHHHH
5.6521406390
393AcetylationDDIERAVDDGVNTFK
HHHHHHHHCCCCEEE
46.0619608861
393UbiquitinationDDIERAVDDGVNTFK
HHHHHHHHCCCCEEE
46.0619608861
398PhosphorylationAVDDGVNTFKVLTRD
HHHCCCCEEEEEECC
23.5621406692
400UbiquitinationDDGVNTFKVLTRDKR
HCCCCEEEEEECCCC
34.0121890473
4002-HydroxyisobutyrylationDDGVNTFKVLTRDKR
HCCCCEEEEEECCCC
34.01-
400AcetylationDDGVNTFKVLTRDKR
HCCCCEEEEEECCCC
34.0119608861
400MalonylationDDGVNTFKVLTRDKR
HCCCCEEEEEECCCC
34.0126320211
400MethylationDDGVNTFKVLTRDKR
HCCCCEEEEEECCCC
34.0119608861
400UbiquitinationDDGVNTFKVLTRDKR
HCCCCEEEEEECCCC
34.0121890473
402UbiquitinationGVNTFKVLTRDKRLV
CCCEEEEEECCCCCC
3.15-
415PhosphorylationLVPGGGATEIELAKQ
CCCCCCHHHHHHHHH
40.5521406692
420UbiquitinationGATEIELAKQITSYG
CHHHHHHHHHHHHCC
6.74-
421UbiquitinationATEIELAKQITSYGE
HHHHHHHHHHHHCCC
55.6621890473
421UbiquitinationATEIELAKQITSYGE
HHHHHHHHHHHHCCC
55.6621890473
421AcetylationATEIELAKQITSYGE
HHHHHHHHHHHHCCC
55.6626051181
421UbiquitinationATEIELAKQITSYGE
HHHHHHHHHHHHCCC
55.6621906983
424PhosphorylationIELAKQITSYGETCP
HHHHHHHHHCCCCCC
17.2528152594
425PhosphorylationELAKQITSYGETCPG
HHHHHHHHCCCCCCC
32.5428152594
426PhosphorylationLAKQITSYGETCPGL
HHHHHHHCCCCCCCH
15.4428152594
429PhosphorylationQITSYGETCPGLEQY
HHHHCCCCCCCHHHH
21.4528152594
430S-nitrosocysteineITSYGETCPGLEQYA
HHHCCCCCCCHHHHH
1.88-
430GlutathionylationITSYGETCPGLEQYA
HHHCCCCCCCHHHHH
1.8822555962
430S-nitrosylationITSYGETCPGLEQYA
HHHCCCCCCCHHHHH
1.8819483679
436PhosphorylationTCPGLEQYAIKKFAE
CCCCHHHHHHHHHHH
10.8328152594
4392-HydroxyisobutyrylationGLEQYAIKKFAEAFE
CHHHHHHHHHHHHHH
33.40-
439AcetylationGLEQYAIKKFAEAFE
CHHHHHHHHHHHHHH
33.4025953088
439UbiquitinationGLEQYAIKKFAEAFE
CHHHHHHHHHHHHHH
33.40-
440UbiquitinationLEQYAIKKFAEAFEA
HHHHHHHHHHHHHHH
43.6321890473
440UbiquitinationLEQYAIKKFAEAFEA
HHHHHHHHHHHHHHH
43.6321890473
440AcetylationLEQYAIKKFAEAFEA
HHHHHHHHHHHHHHH
43.6325953088
440SuccinylationLEQYAIKKFAEAFEA
HHHHHHHHHHHHHHH
43.6323954790
440UbiquitinationLEQYAIKKFAEAFEA
HHHHHHHHHHHHHHH
43.6321890473
447AcetylationKFAEAFEAIPRALAE
HHHHHHHHHHHHHHH
15.61-
447UbiquitinationKFAEAFEAIPRALAE
HHHHHHHHHHHHHHH
15.6121890473
447AcetylationKFAEAFEAIPRALAE
HHHHHHHHHHHHHHH
15.6119608861
447UbiquitinationKFAEAFEAIPRALAE
HHHHHHHHHHHHHHH
15.6119608861
4592-HydroxyisobutyrylationLAENSGVKANEVISK
HHHCCCCCHHHHHHH
49.36-
459SumoylationLAENSGVKANEVISK
HHHCCCCCHHHHHHH
49.3625114211
459UbiquitinationLAENSGVKANEVISK
HHHCCCCCHHHHHHH
49.3621906983
466UbiquitinationKANEVISKLYAVHQE
CHHHHHHHHHHHHHC
34.1021890473
4662-HydroxyisobutyrylationKANEVISKLYAVHQE
CHHHHHHHHHHHHHC
34.10-
466AcetylationKANEVISKLYAVHQE
CHHHHHHHHHHHHHC
34.1019608861
466MalonylationKANEVISKLYAVHQE
CHHHHHHHHHHHHHC
34.1026320211
466UbiquitinationKANEVISKLYAVHQE
CHHHHHHHHHHHHHC
34.1021890473
468NitrationNEVISKLYAVHQEGN
HHHHHHHHHHHHCCC
15.43-
468PhosphorylationNEVISKLYAVHQEGN
HHHHHHHHHHHHCCC
15.4328152594
492SulfoxidationEVPAVKDMLEAGILD
ECCHHHHHHHHCCHH
2.7830846556
501PhosphorylationEAGILDTYLGKYWAI
HHCCHHHHHHHHHHH
17.0825147952
505PhosphorylationLDTYLGKYWAIKLAT
HHHHHHHHHHHHHHH
9.7722817900
509AcetylationLGKYWAIKLATNAAV
HHHHHHHHHHHCCCE
25.07-
509UbiquitinationLGKYWAIKLATNAAV
HHHHHHHHHHHCCCE
25.0721890473
512PhosphorylationYWAIKLATNAAVTVL
HHHHHHHHCCCEEEE
35.5120860994
515UbiquitinationIKLATNAAVTVLRVD
HHHHHCCCEEEEEEC
10.28-
517PhosphorylationLATNAAVTVLRVDQI
HHHCCCEEEEEECEE
14.7520860994
520UbiquitinationNAAVTVLRVDQIIMA
CCCEEEEEECEEEEE
26.15-
521UbiquitinationAAVTVLRVDQIIMAK
CCEEEEEECEEEEEC
5.78-
526SulfoxidationLRVDQIIMAKPAGGP
EEECEEEEECCCCCC
4.1321406390
528UbiquitinationVDQIIMAKPAGGPKP
ECEEEEECCCCCCCC
20.3021890473
528AcetylationVDQIIMAKPAGGPKP
ECEEEEECCCCCCCC
20.3023749302
528MalonylationVDQIIMAKPAGGPKP
ECEEEEECCCCCCCC
20.3026320211
528MethylationVDQIIMAKPAGGPKP
ECEEEEECCCCCCCC
20.30-
528UbiquitinationVDQIIMAKPAGGPKP
ECEEEEECCCCCCCC
20.3021890473
534SumoylationAKPAGGPKPPSGKKD
ECCCCCCCCCCCCCC
73.22-
534AcetylationAKPAGGPKPPSGKKD
ECCCCCCCCCCCCCC
73.2226210075
534SumoylationAKPAGGPKPPSGKKD
ECCCCCCCCCCCCCC
73.2228112733
534UbiquitinationAKPAGGPKPPSGKKD
ECCCCCCCCCCCCCC
73.22-
537PhosphorylationAGGPKPPSGKKDWDD
CCCCCCCCCCCCCCC
72.3023401153
5392-HydroxyisobutyrylationGPKPPSGKKDWDDDQ
CCCCCCCCCCCCCCC
52.47-
539AcetylationGPKPPSGKKDWDDDQ
CCCCCCCCCCCCCCC
52.4725953088
539SumoylationGPKPPSGKKDWDDDQ
CCCCCCCCCCCCCCC
52.4728112733
539UbiquitinationGPKPPSGKKDWDDDQ
CCCCCCCCCCCCCCC
52.47-
540AcetylationPKPPSGKKDWDDDQN
CCCCCCCCCCCCCCC
68.5212430811
540UbiquitinationPKPPSGKKDWDDDQN
CCCCCCCCCCCCCCC
68.5221906983

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of TCPQ_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TCPQ_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TCPQ_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
A4_HUMANAPPphysical
21832049
TCPZ_HUMANCCT6Aphysical
22939629
TIF1B_HUMANTRIM28physical
22939629
VATB2_HUMANATP6V1B2physical
22939629
UBA5_HUMANUBA5physical
22939629
TCPB_HUMANCCT2physical
22863883
AT1A1_HUMANATP1A1physical
26344197
GFPT1_HUMANGFPT1physical
26344197
IMA3_HUMANKPNA4physical
26344197
MESD_HUMANMESDC2physical
26344197
PRS7_HUMANPSMC2physical
26344197
RPN1_HUMANRPN1physical
26344197
TBB5_HUMANTUBBphysical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TCPQ_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-7; LYS-318; LYS-400 ANDLYS-466, AND MASS SPECTROMETRY.
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey.";
Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
Mol. Cell 23:607-618(2006).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-20, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23 AND TYR-30, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-227; THR-232 ANDSER-233, AND MASS SPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-505, AND MASSSPECTROMETRY.
Ubiquitylation
ReferencePubMed
"Tryptic digestion of ubiquitin standards reveals an improved strategyfor identifying ubiquitinated proteins by mass spectrometry.";
Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.;
Proteomics 7:868-874(2007).
Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-225 AND LYS-235, AND MASSSPECTROMETRY.

TOP